Considering the cytotoxic effect of CA and CAPE (measured in this study by three methods), we clearly see that these two substances are active against MDA-MB-231 breast cancer cells, with CAPE displaying IC50 values more than twice as low as CA. The gene discussed is SMC2; the disease is breast carcinoma.